These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21425269)

  • 1. Progressive multiple sclerosis and gray matter pathology: an MRI perspective.
    Inglese M; Oesingmann N; Casaccia P; Fleysher L
    Mt Sinai J Med; 2011; 78(2):258-67. PubMed ID: 21425269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion imaging in multiple sclerosis: research and clinical implications.
    Inglese M; Bester M
    NMR Biomed; 2010 Aug; 23(7):865-72. PubMed ID: 20882528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI outcomes in the diagnosis and disease course of multiple sclerosis.
    Simon JH
    Handb Clin Neurol; 2014; 122():405-25. PubMed ID: 24507528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI in multiple sclerosis: a review of the current literature.
    Ceccarelli A; Bakshi R; Neema M
    Curr Opin Neurol; 2012 Aug; 25(4):402-9. PubMed ID: 22691759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on multiple sclerosis.
    Simon JH
    Radiol Clin North Am; 2006 Jan; 44(1):79-100, viii. PubMed ID: 16297683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
    Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H; Geurts JJ
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MRI in multiple sclerosis II: brain and spinal cord atrophy.
    Zivadinov R; Bakshi R
    Front Biosci; 2004 Jan; 9():647-64. PubMed ID: 14766398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal damage in multiple sclerosis patients with high versus low expanded disability status scale score.
    Brass SD; Narayanan S; Antel JP; Lapierre Y; Collins L; Arnold DL
    Can J Neurol Sci; 2004 May; 31(2):225-8. PubMed ID: 15198448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
    Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
    Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques.
    Filippi M; Tortorella C; Bozzali M
    Mult Scler; 1999 Aug; 5(4):273-82. PubMed ID: 10467388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.
    Kearney H; Miller DH; Ciccarelli O
    Nat Rev Neurol; 2015 Jun; 11(6):327-38. PubMed ID: 26009002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.
    Filippi M; Rocca MA
    J Neurol; 2005 Nov; 252 Suppl 5():v16-24. PubMed ID: 16254697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
    Miller DH; Grossman RI; Reingold SC; McFarland HF
    Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.